Sirt1
Showing 1 - 25 of 217
SIRT1(rs7069102 ) Gene Polymorphism in Chronic Obstructive
Recruiting
- Genotyping of SIRT1in Chronic Obstructive Pulmonary Disease
- genotyping of SIRT1 in chronic obstructive patients
-
Sohag, EgyptSohag university Hospital
Sep 20, 2023
Endometriosis, Uterine Diseases, Endometrial Diseases Trial in Winston-Salem (EX-527 (Selisistat), Placebo)
Withdrawn
- Endometriosis
- +4 more
- EX-527 (Selisistat)
- Placebo
-
Winston-Salem, North CarolinaWake Forest School of Medicine
Nov 8, 2021
Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,
Not yet recruiting
- Resectable Hepatocellular Carcinoma
- +2 more
- Durvalumab
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 18, 2023
WNT4 VEZT FSHB and SIRT1 SNPs in Endometriosis:Case Control
Recruiting
- Polymorphism (Genetics)
- Endometriosis
- SNPs analysis with Sanger sequencing
-
Monserrato, Cagliari, ItalyUniversity of Cagliari,Obstetrics and Gynecological Department,
Feb 12, 2021
Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Carcinoma Trial in Ann Arbor (drug, device, radiation, diagnostic
Recruiting
- Hepatocellular Carcinoma (HCC)
- Unresectable Hepatocellular Carcinoma
- Yttrium-90
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 16, 2021
Intrahepatic Cholangiocarcinoma Trial in Worldwide (Cisplatin-gemcitabine, Radiation: SIRT + chemo (cisplatin-gemcitabine))
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
- Cisplatin-gemcitabine
- Radiation: SIRT + chemotherapy (cisplatin-gemcitabine)
-
Spokane, Washington
- +22 more
Apr 1, 2022
COPD Trial in Richmond (Resveratrol, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Resveratrol
- Placebo
-
Richmond, VirginiaVirginia Commonwealth University
Jan 31, 2023
Epithelial-to-mesenchymal Transition in Breast Cancer Lymph
Unknown status
- Breast Cancer
- Lymph Node Metastases
-
Beijing, Beijing, ChinaPeking university people's hospital
Oct 22, 2019
Coronary Artery Disease, Menopause Trial in Sao Paulo (Quercetin, Placebo)
Recruiting
- Coronary Artery Disease
- Menopause
- Quercetin
- Placebo
-
Sao Paulo, São Paulo, BrazilINCOR- Heart Institute
May 17, 2023
Endometriosis, Unexplained Infertility Trial in Winston-Salem (Elagolix, Oral Contraceptive)
Recruiting
- Endometriosis
- Unexplained Infertility
- Elagolix
- Oral Contraceptive
-
Winston-Salem, North CarolinaWake Forest Univesity Health Sciences
Dec 1, 2022
DM Trial in Cairo (life style, Metformin, Nigetella salivata)
Recruiting
- DM
- life style
- +2 more
-
Cairo, EgyptSherief Abd-Elsalam
Apr 22, 2019
Type 1 Diabetes Trial in Augusta (Resveratrol, Placebo)
Recruiting
- Type 1 Diabetes
- Resveratrol
- Placebo
-
Augusta, GeorgiaAugusta University/Georgia Prevention Institute/ Laboratory of I
Jul 18, 2022
Anthracycline Related Cardiotoxicity in Breast Cancer Trial in Lubbock (sulforaphane, Placebo Oral Tablet)
Recruiting
- Anthracycline Related Cardiotoxicity in Breast Cancer
- sulforaphane
- Placebo Oral Tablet
-
Lubbock, TexasTexas Tech University Health Sciences Center
Jul 18, 2022
NAD+/NADH in Peripheral Blood Samples of Different Gender and
Not yet recruiting
- NAD+/NADH in Peripheral Blood Monitoring
- Detection of NAD+/NADH concentration of Peripheral Blood Samples
-
Shanghai, Shanghai, ChinaShanghai Mengchao Cancer Hospital
Aug 11, 2023
PCOS Trial in Swabi (dietary supplement, drug, combination product)
Recruiting
- PCOS
- Resveratrol
- +2 more
-
Swabi, Khyber Pukhtunkhwa, PakistanBacha Khan Medical Complex Swabi
Dec 15, 2022
Knee Osteoarthritis, Metformin Trial in Dhaka (Metformin 500 Mg extended release Oral Tablet, Placebo oral tablet)
Recruiting
- Knee Osteoarthritis
- Metformin
- Metformin 500 Mg extended release Oral Tablet
- Placebo oral tablet
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
Nov 13, 2023
Alcohol-Related Disorders Trial in Los Angeles (Dihydromyricetin)
Not yet recruiting
- Alcohol-Related Disorders
-
Los Angeles, CaliforniaUniversity of Southern California
Nov 11, 2022
Hepatocellular Carcinoma Trial in Guangzhou (SIRT)
Not yet recruiting
- Hepatocellular Carcinoma
- SIRT
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Aug 9, 2023
Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, sintilimab plus SIRT)
Not yet recruiting
- Hepatocellular Carcinoma
- Lenvatinib, sintilimab plus SIRT
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Aug 8, 2023
Aerobic Endurance, Metabolism Trial in Natick (High-amylose maize starch+acetate/butyrate, Low-amylose maize starch)
Recruiting
- Aerobic Endurance
- Metabolism
- High-amylose maize starch+acetate/butyrate
- Low-amylose maize starch
-
Natick, MassachusettsUnited States Army Research Institute of Environmental Medicine
Sep 19, 2023
Post-COVID Syndrome Trial in Terrassa (RehabCovid_Telematic, RehabCovid_ImmersiveVR, Control_Condition)
Recruiting
- Post-COVID Syndrome
- RehabCovid_Telematic
- +2 more
-
Terrassa, SpainConsorci Sanitari de Terrassa
May 4, 2023
Cardiovascular Diseases, Diabetes, Type 2, Obesity Trial in Manchester (Exercise training in the fasted state, Exercise training
Not yet recruiting
- Cardiovascular Diseases
- +2 more
- Exercise training in the fasted state
- Exercise training in the fed state
-
Manchester, Greater Manchester, United KingdomManchester Metropolitan University
Feb 23, 2023
Diabetes, Type 2 Trial in Tanta (Glimepiride Tablets, glimepiride plus fenofibrate, glimepiride plus curcumin)
Completed
- Diabetes Mellitus, Type 2
- Glimepiride Tablets
- +2 more
-
Tanta, El-Gharbia, EgyptTanta University Hospital
Feb 16, 2022
Hepatocellular Carcinoma Non-resectable Trial (Selective Internal Radiation Therapy with 188Re-SSS lipiodol)
Not yet recruiting
- Hepatocellular Carcinoma Non-resectable
- Selective Internal Radiation Therapy with 188Re-SSS lipiodol
- (no location specified)
Mar 22, 2023
Locally Advanced Hepatocellular Carcinoma Trial in Singapore (SIRT-Y90 with Atezolizumab + Bevacizumab, SIRT-Y90 with Placebo
Recruiting
- Locally Advanced Hepatocellular Carcinoma
- SIRT-Y90 with Atezolizumab + Bevacizumab
- SIRT-Y90 with Placebo (IV)
-
Singapore, Singapore
- +1 more
Jan 26, 2023